| Filed On | Filing |
|---|---|
| 25 Sep 2026 |
Form 3: Cumbo Alexander, Director
No securities owned |
| 17 Jul 2026 |
Form 3: McCauley Thomas, Chief Scientific Officer
No securities owned |
| 07 Apr 2026 |
Form 3: Kahn Clare, Director
No securities owned |
| 23 Jun 2025 |
Form 3: Hoitt Jason, Chief Patient Officer
Holds 1,802 shares of Common Stock |
| 17 May 2024 |
Form 3: Leggett Thomas, Chief Financial Officer
No securities owned |
| 20 Sep 2023 |
Form 3: Smith Ian F, Director
No securities owned |
| 17 Mar 2023 |
Form 3: Allan Jonathan, General Counsel & Corp Sec
Holds 1,948 shares of Common Stock |
| 30 Jun 2021 |
Form 3: Skorpios Trust, 10% owner and 3 others
Holds 14,443,681 shares of Common Stock |
| 27 Jan 2021 |
Form 3: Menzel Garry E, Director
Holds 0 shares of No securities beneficially held |
| 05 Jun 2020 |
Form 3: Smith Julie, Director
Holds 0 shares of No securities beneficially held |
| 18 Nov 2019 |
Form 3: Walker Robin A., Chief Legal Officer
Holds 0 shares of No securities beneficially owned |
| 19 Jun 2019 |
Form 3: Burstein Jennifer, Director
Holds 0 shares of No Securities are beneficially owned |
| 18 Jun 2019 | Form 3: Tulipano Stephen J, Chief Financial Officer |
| 18 Jun 2019 |
Form 3: Hall Samuel W., Director
Holds 0 shares of No Securities are beneficially owned |
| 18 Jun 2019 | Form 3: Nash Huw M., COO & CBO |
| 18 Jun 2019 | Form 3: Liau Gene, EVP, Head of Research |
| 18 Jun 2019 | Form 3: Kaye Edward M. Md, Director |
| 18 Jun 2019 | Form 3: Ticho Barry, Chief Medical Officer |
| 18 Jun 2019 |
Form 3: Levin Arthur A, Director
Holds 17,979 shares of Common Stock |
| 18 Jun 2019 | Form 3: Tzianabos Arthur, Director |
Loading...